CANF
Can-Fite BioPharma
CANF
CANF
7 hedge funds and large institutions have $225K invested in Can-Fite BioPharma in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$107K |
2 |
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$13K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$2K |
Top Sellers
1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$0 |
2 |
2
Morgan Stanley
New York
|
$100K |
3 |
3
Citadel Advisors
Miami,
Florida
|
$0 |